Kaj E. C. Blokland

746 total citations
15 papers, 553 citations indexed

About

Kaj E. C. Blokland is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Kaj E. C. Blokland has authored 15 papers receiving a total of 553 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 7 papers in Physiology and 3 papers in Molecular Biology. Recurrent topics in Kaj E. C. Blokland's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers), Occupational and environmental lung diseases (5 papers) and Histiocytic Disorders and Treatments (3 papers). Kaj E. C. Blokland is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers), Occupational and environmental lung diseases (5 papers) and Histiocytic Disorders and Treatments (3 papers). Kaj E. C. Blokland collaborates with scholars based in Australia, Netherlands and Canada. Kaj E. C. Blokland's co-authors include Janette K. Burgess, Michael Schuliga, Darryl A. Knight, Christopher Grainge, Steven E. Mutsaers, Cecilia M. Prêle, David W. Waters, Simon D. Pouwels, Prabuddha S. Pathinayake and Jade Jaffar and has published in prestigious journals such as Biomaterials, American Journal of Respiratory and Critical Care Medicine and American Journal of Respiratory Cell and Molecular Biology.

In The Last Decade

Kaj E. C. Blokland

14 papers receiving 550 citations

Peers

Countries citing papers authored by Kaj E. C. Blokland

Since Specialization

Citations

This map shows the geographic impact of Kaj E. C. Blokland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaj E. C. Blokland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaj E. C. Blokland more than expected).

Fields of papers citing papers by Kaj E. C. Blokland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kaj E. C. Blokland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaj E. C. Blokland. The network helps show where Kaj E. C. Blokland may publish in the future.

Co-authorship network of co-authors of Kaj E. C. Blokland

This figure shows the co-authorship network connecting the top 25 collaborators of Kaj E. C. Blokland. A scholar is included among the top collaborators of Kaj E. C. Blokland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaj E. C. Blokland. Kaj E. C. Blokland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Chronic Airways Assessment Test (CAAT) in a Nationally Representative Adult Population With Asthma and/or COPD 2025 ·American Journal of Respiratory and Critical Care Medicine ·Helen K. Reddel, R Ampon, Kaj E. C. Blokland, Brett G. Toelle, Paul Jones, (unknown), Leanne Poulos	0
2	The effect of expiratory flow limitation on supine persistent hyperinflation in COPD: a prospective observational study 2024 ·ERJ Open Research ·Meera Srinivasan, H. Marvin Pollard, David G. Chapman, Katrina O. Tonga, (unknown), Kaj E. C. Blokland, (unknown), Cindy Thamrin, Troy J. Cross, (unknown), Gregory G. King	1
3	Substrate stiffness engineered to replicate disease conditions influence senescence and fibrotic responses in primary lung fibroblasts 2022 ·Frontiers in Pharmacology ·Kaj E. C. Blokland, (unknown), (unknown), Theo Borghuis, Michael Schuliga, Barbro N. Melgert, Darryl A. Knight, Corry‐Anke Brandsma, Simon D. Pouwels, Janette K. Burgess	26
4	Regulation of Cellular Senescence Is Independent from Profibrotic Fibroblast-Deposited ECM 2021 ·Cells ·Kaj E. C. Blokland, (unknown), Theo Borghuis, (unknown), Michael Schuliga, Barbro N. Melgert, Darryl A. Knight, Corry‐Anke Brandsma, Simon D. Pouwels, Janette K. Burgess	12
5	A Senescence Bystander Effect in Human Lung Fibroblasts 2021 ·Biomedicines ·David W. Waters, Michael Schuliga, Prabuddha S. Pathinayake, Lan Wei, (unknown), Kaj E. C. Blokland, Jade Jaffar, Glen Westall, Janette K. Burgess, Cecilia M. Prêle, Steven E. Mutsaers, Christopher Grainge, Darryl A. Knight	18
6	A cGAS-dependent response links DNA damage and senescence in alveolar epithelial cells: a potential drug target in IPF 2021 ·American Journal of Physiology-Lung Cellular and Molecular Physiology ·Michael Schuliga, (unknown), Jane Read, Kaj E. C. Blokland, Janette K. Burgess, Cecilia M. Prêle, Steven E. Mutsaers, Christopher Grainge, Claire Thomson, James B. Allen, Nathan W. Bartlett, Darryl A. Knight	29
7	Regulation of cellular senescence by extracellular matrix during chronic fibrotic diseases 2020 ·Clinical Science ·Kaj E. C. Blokland, Simon D. Pouwels, Michael Schuliga, Darryl A. Knight, Janette K. Burgess	84
8	Senescence of IPF Lung Fibroblasts Disrupt Alveolar Epithelial Cell Proliferation and Promote Migration in Wound Healing 2020 ·Pharmaceutics ·Kaj E. C. Blokland, David W. Waters, Michael Schuliga, Jane Read, Simon D. Pouwels, Christopher Grainge, Jade Jaffar, Glen Westall, Steven E. Mutsaers, Cecilia M. Prêle, Janette K. Burgess, Darryl A. Knight	41
9	Self DNA perpetuates IPF lung fibroblast senescence in a cGAS-dependent manner 2020 ·Clinical Science ·Michael Schuliga, Jane Read, Kaj E. C. Blokland, David W. Waters, Janette K. Burgess, Cecilia M. Prêle, Steven E. Mutsaers, Jade Jaffar, Glen Westall, Andrew T. Reid, James B. Allen, Christopher Grainge, Darryl A. Knight	42
10	STAT3 Regulates the Onset of Oxidant-induced Senescence in Lung Fibroblasts 2019 ·American Journal of Respiratory Cell and Molecular Biology ·David W. Waters, Kaj E. C. Blokland, Prabuddha S. Pathinayake, Lan Wei, Michael Schuliga, Jade Jaffar, Glen Westall, Philip M. Hansbro, Cecilia M. Prêle, Steven E. Mutsaers, Nathan W. Bartlett, Janette K. Burgess, Christopher Grainge, Darryl A. Knight	56
11	Extracellular vesicles in lung health, disease, and therapy 2019 ·American Journal of Physiology-Lung Cellular and Molecular Physiology ·Mark J. McVey, Mazharul Maishan, Kaj E. C. Blokland, Nathan W. Bartlett, Wolfgang M. Kuebler	47
12	Alveolar epithelial wound repair is delayed by scenescent lung fibroblasts in IPF 2019 ·UWA Profiles and Research Repository (University of Western Australia) ·Kaj E. C. Blokland, David W. Waters, Michael Schuliga, Simon D. Pouwels, Christopher Grainge, Steven E. Mutsaers, Cecilia M. Prêle, (unknown), Jade Jaffar, Darryl A. Knight, Janette K. Burgess	1
13	Sustained and regulated gene expression by Tet-inducible “all-in-one” retroviral vectors containing the HNRPA2B1-CBX3 UCOE® 2018 ·Biomaterials ·(unknown), Kaj E. C. Blokland, Attila Sebe, (unknown), Zoltán Ivics, Niels Heinz, Ute Modlich	10
14	Mitochondrial dysfunction contributes to the senescent phenotype of IPF lung fibroblasts 2018 ·Journal of Cellular and Molecular Medicine ·Michael Schuliga, Dmitri V. Pechkovsky, Jane Read, David W. Waters, Kaj E. C. Blokland, Andrew T. Reid, Cory M. Hogaboam, Nasreen Khalil, Janette K. Burgess, Cecilia M. Prêle, Steven E. Mutsaers, Jade Jaffar, Glen Westall, Christopher Grainge, Darryl A. Knight	67
15	Fibroblast senescence in the pathology of idiopathic pulmonary fibrosis 2018 ·American Journal of Physiology-Lung Cellular and Molecular Physiology ·David W. Waters, Kaj E. C. Blokland, Prabuddha S. Pathinayake, Janette K. Burgess, Steven E. Mutsaers, Cecilia M. Prêle, Michael Schuliga, Christopher Grainge, Darryl A. Knight	119

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact